The two most common alleles of the coding GGN repeat in the androgen receptor gene cause differences in protein function

Journal of Molecular Endocrinology

Volumn 39, Issue 1-2, 2007, Pages 1-8

  Brockschmidt, Felix F ^a   Nöthen, Markus M ^a   Hillmer, Axel M ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; ASPARAGINE; GLYCINE; GUANINE;

ALLELE; ARTICLE; BLOOD DONOR; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; EXON; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC TRAIT; GENETIC TRANSCRIPTION; GENOTYPE; HELA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; NORMAL HUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN STABILITY; REAL TIME POLYMERASE CHAIN REACTION; REPORTER GENE; TRANSLATION REGULATION; TRINUCLEOTIDE REPEAT; WESTERN BLOTTING;

BLOOD DONORS; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXONS; GENES, REPORTER; GENETIC CODE; HELA CELLS; HUMANS; LUCIFERASES; MALE; PEPTIDES; POLYMERASE CHAIN REACTION; RECEPTORS, ANDROGEN; TRINUCLEOTIDE REPEATS;

EID: 34548329696     PISSN: 09525041     EISSN: None     Source Type: Journal    
DOI: 10.1677/JME-06-0072     Document Type: Article

References (37)

1. Alléra A, Wolff M, Watzka M, Daufeldt S, Sinnecker G & Bidlingmaier F 1998 Partial androgen insensitivity syndrome (AIS) in patients with a normal androgen receptor (AR) gene seqeunce is possibly caused by an activated but abnormally working AR. 10th International Congress on Hormonal Steroids, Québec City, Canada. Abstract 86.
2. Aschim EL, Nordenskjold A, Giwercman A, Lundin KB, Ruhayel Y, Haugen TB, Grotmol T & Giwercman YL 2004 Linkage between cryptorchidism, hypospadias, and GGN repeat length in the androgen receptor gene. Journal of Clinical Endocrinology and Metabolism 89 5105-5109.
3. Avila DM, Zoppi S & McPhaul MJ 2001 The androgen receptor (AR) in syndromes of androgen insensitivity and in prostate cancer. Journal of Steroid Biochemistry and Molecular Biology 76 135-142.
4. Buchanan G, Yang M, Cheong A, Harris JM, Irvine RA, Lambert PF, Moore NL, Raynor M, Neufing PJ, Coetzee GA et al. 2004 Structural and functional consequences of glutamine tract variation in the androgen receptor. Human Molecular Genetics 13 1677-1692.
5. Chamberlain NL, Driver ED & Miesfeld RL 1994 The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acids Research 22 3181-3186.
6. Chang BL, Zheng SL, Hawkins GA, Isaacs SD, Wiley KE, Turner A, Carpten JD, Bleecker ER, Walsh PC, Trent JM et al. 2002 Polymorphic GGC repeats in the androgen receptor gene are associated with hereditary and sporadic prostate cancer risk. Human Genetics 110 122-129.
7. Cohen JC, Kiss RS, Pertsemlidis A, Marcel YL, McPherson R & Hobbs HH 2004 Multiple rare alleles contribute to low plasma levels of HDL cholesterol. Science 305 869-872.
8. Cox DG, Blanche H, Pearce CL, Calle EE, Colditz GA, Pike MC, Albanes D, Allen NE, Amiano P, Berglund G et al. 2006 A comprehensive analysis of the androgen receptor gene and risk of breast cancer: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3). Breast Cancer Research 8 R54.
9. Ding D, Xu L, Menon M, Reddy GP & Barrack ER 2005 Effect of GGC (glycine) repeat length polymorphism in the human androgen receptor on androgen action. Prostate 62 133-139.
10. Dunning AM, McBride S, Gregory J, Durocher F, Foster NA, Healey CS, Smith N, Pharoah PD, Luben RN, Easton DF et al. 1999 No association between androgen or vitamin D receptor gene polymorphisms and risk of breast cancer. Carcinogenesis 20 2131-2135.
11. Edwards SM, Badzioch MD, Minter R, Hamoudi R, Collins N, Ardern-Jones A, Dowe A, Osborne S, Kelly J, Shearer R et al. 1999 Androgen receptor polymorphisms: association with prostate cancer risk, relapse and overall survival. International Journal of Cancer 84 458-465.
12. Ellis JA, Stebbing M & Harrap SB 2001 Polymorphism of the androgen receptor gene is associated with male pattern baldness. Journal of Investigative Dermatology 116 452-455.
13. Ferlin A, Bartoloni L, Rizzo G, Roverato A, Garolla A & Foresta C 2004 Androgen receptor gene CAG and GGC repeat lengths in idiopathic male infertility. Molecular Human Reproduction 10 417-421.
14. Gao T, Marcelli M & McPhaul MJ 1996 Transcriptional activation and transient expression of the human androgen receptor. Journal of Steroid Biochemistry and Molecular Biology 59 9-20.
15. Hillmer AM, Hanneken S, Ritzmann S, Becker T, Freudenberg J, Brockschmidt FF, Flaquer A, Freudenberg-Hua Y, Jamra RA, Metzen C et al. 2005 Genetic variation in the human androgen receptor gene is the major determinant of common early-onset androgenetic alopecia. American Journal of Human Genetics 77 140-148.
16. Hsing AW, Gao YT, Wu G, Wang X, Deng J, Chen YL, Sesterhenn IA, Mostofi FK, Benichou J & Chang C 2000 Polymorphic CAG and GGN repeat lengths in the androgen receptor gene and prostate cancer risk: a population-based case-control study in China. Cancer Research 60 5111-5116.
17. Kadouri L, Easton DF, Edwards S, Hubert A, Kote-Jarai Z, Glaser B, Durocher F, Abeliovich D, Peretz T & Eeles RA 2001 CAG and GGC repeat polymorphisms in the androgen receptor gene and breast cancer susceptibility in BRCA1/2 carriers and non-carriers. British Journal of Cancer 85 36-40.
18. Kazemi-Esfarjani P, Trifiro, MA & Pinsky L 1995 Evidence for a repressive function of the long polyglutamine tract in the human androgen receptor: possible pathogenetic relevance for the (CAG) n-expanded neuronopathies. Human Molecular Genetics 4 523-527.
19. Kittles RA, Young D, Weinrich S, Hudson J, Argyropoulos G, Ukoli F, Adams-Campbell L & Dunston GM 2001 Extent of linkage disequilibrium between the androgen receptor gene CAG and GGC repeats in human populations: implications for prostate cancer risk. Human Genetics 109 253-261.
20. Lander ES 1996 The new genomics: global views of biology. Science 274 536-539.
21. Lee HJ & Chang C 2003 Recent advances in androgen receptor action. Cellular and Molecular Life Sciences 60 1613-1622.
22. Lumbroso R, Beitel LK, Vasiliou DM, Trifiro MA & Pinsky L 1997 Codon-usage variants in the polymorphic (GGN) n trinucleotide repeat of the human androgen receptor gene. Human Genetics 101 43-46.
23. Lundin KB, Giwercman YL, Rylander L, Hagmar L & Giwercman A 2006 Androgen receptor gene GGN repeat length and reproductive characteristics in young Swedish men. European Journal of Endocrinology 155 347-354.
24. Lundin KB, Giwercrnan A, Dizeyi N & Giwercman YL 2007 Functional in vitro characterisation of the androgen receptor GGN polymorphism. Molecular and Cellular Endocrinology 264 184-187.
25. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schutz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P et al. 1995 The nuclear receptor superfamily: the second decade. Cell 83 835-839.
26. Mhatre AN, Trifiro MA, Kaufman M, Kazemi-Esfarjani P, Figlewicz D, Rouleau G & Pinsky L 1993 Reduced transcriptional regulatory competence of the androgen receptor in X-linked spinal and bulbar muscular atrophy. Nature Genetics 5 184-188.
27. Miller SA, Dykes DD & Polesky HF 1988 A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Research 16 1215.
28. Nakajima H, Kimura F, Nakagawa T, Furutama D, Shinoda K, Shimizu A & Ohsawa N 1996 Transcriptional activation by the androgen receptor in X-linked spinal and bulbar muscular atrophy. Journal of the Neurological Sciences 142 12-16.
29. Pritchard JK & Cox NJ 2002 The allelic architecture of human disease genes: common disease-common variant... or not? Human Molecular Genetics 11 2417-2423.
30. Quigley CA, De Bellis A, Marschke KB, el-Awady MK, Wilson EM & French FS 1995 Androgen receptor defects: historical, clinical, and molecular perspectives. Endocrine Reviews 16 271-321.
31. Ruhayel Y, Lundin K, Giwercman Y, Hallden C, Willen M & Giwercman A 2004 Androgen receptor gene GGN and CAG polymorphisms among severely oligozoospermic and azoospermic Swedish men. Human Reproduction 19 2076-2083.
32. Sambrook J & Russel DW 2001 In Molecular Cloning: a Laboratory Manual, 3rd edn, pp A8.40-A8.45. Ed J Argentine. Cold Spring Harbor: Cold Spring Harbor Laboratory Press.
33. Sasaki M, Karube A, Karube Y, Watari M, Sakuragi N, Fujimoto S & Dahiya R 2005 GGC and Stul polymorphism on the androgen receptor gene in endometrial cancer patients. Biochemical and Biophysical Research Communications 329 100-104.
34. Suter NM, Malone KE, Daling JR, Doody DR & Ostrander EA 2003 Androgen receptor (CAG) n and (GGC) n polymorphisms and breast cancer risk in a population-based case-control study of young women. Cancer Epidemiology, Biomarkers and Prevention 12 127-135.
35. Wang Q, Udayakumar TS, Vasaitis TS, Brodie AM & Fondell JD 2004 Mechanistic relationship between androgen receptor polyglutamine tract truncation and androgen-dependent transcriptional hyperactivity in prostate cancer cells. Journal of Biological Chemistry 279 17319-17328.
36. Werner R, Holterhus PM, Binder G, Schwarz HP, Morlot M, Struve D, Marschke C & Hiort O 2006 The A645D mutation in the hinge region of the human androgen receptor (AR) gene modulates AR activity, depending on the context of the polymorphic glutamine and glycine repeats. Journal of Clinical Endocrinology and Metabolism 91 3515-3520.
37. Zeegers MP, Kiemeney LA, Nieder AM & Ostrer H 2004 How strong is the association between CAG and GGN repeat length polymorphisms in the androgen receptor gene and prostate cancer risk? Cancer Epidemiology, Biomarkers and Prevention 13 1765-1771.